Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Kao

Concepts (371)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
34
2024
2228
5.190
Why?
Machine Learning
7
2024
487
2.320
Why?
Stroke Volume
17
2025
619
2.000
Why?
Methadone
5
2023
98
1.570
Why?
Adrenergic beta-Antagonists
10
2025
323
1.540
Why?
Pregnancy Complications, Cardiovascular
5
2022
77
1.510
Why?
Buprenorphine
3
2023
167
1.400
Why?
Cardiomyopathies
5
2022
350
1.370
Why?
Decision Support Systems, Clinical
6
2024
218
1.280
Why?
United States Food and Drug Administration
5
2024
207
1.260
Why?
Pharmacogenetics
5
2024
179
1.170
Why?
Cardiomyopathy, Dilated
9
2025
383
1.160
Why?
Adverse Drug Reaction Reporting Systems
4
2024
77
1.140
Why?
Arrhythmias, Cardiac
6
2023
331
1.120
Why?
Electronic Health Records
7
2024
1036
1.050
Why?
Cytochrome P-450 CYP2C19
4
2024
24
1.020
Why?
Hospitalization
10
2024
2195
0.920
Why?
Propanolamines
3
2019
96
0.920
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
442
0.890
Why?
Workflow
1
2024
165
0.830
Why?
Telemedicine
4
2024
847
0.810
Why?
Torsades de Pointes
4
2016
23
0.760
Why?
Seasons
1
2024
544
0.750
Why?
Pulmonary Edema
1
2021
106
0.730
Why?
Humans
85
2025
136783
0.720
Why?
Coffee
1
2021
17
0.710
Why?
Stroke
2
2021
1129
0.690
Why?
Pharmacogenomic Testing
4
2022
64
0.680
Why?
Platelet Aggregation Inhibitors
1
2024
460
0.670
Why?
Defibrillators, Implantable
2
2021
315
0.660
Why?
Aged
31
2025
23729
0.640
Why?
Prosthesis-Related Infections
1
2020
80
0.620
Why?
Prosthesis Failure
1
2020
116
0.620
Why?
Long QT Syndrome
3
2016
70
0.610
Why?
Spironolactone
1
2019
35
0.610
Why?
Mobile Applications
1
2021
180
0.610
Why?
Device Removal
1
2020
138
0.600
Why?
Pacemaker, Artificial
1
2020
119
0.600
Why?
United States
21
2024
14660
0.600
Why?
Mineralocorticoid Receptor Antagonists
1
2019
54
0.590
Why?
Medical Records
2
2019
172
0.590
Why?
Coronary Disease
1
2021
385
0.580
Why?
Diabetes Mellitus
2
2024
1033
0.580
Why?
Biomedical Research
2
2024
689
0.580
Why?
Periodicals as Topic
1
2020
210
0.570
Why?
Mortality
3
2019
357
0.560
Why?
Retrospective Studies
21
2024
15564
0.550
Why?
Risk Assessment
8
2024
3429
0.540
Why?
Hypertension, Pregnancy-Induced
1
2018
68
0.530
Why?
Female
48
2025
72840
0.530
Why?
Receptors, Transforming Growth Factor beta
1
2017
59
0.530
Why?
Analgesics, Opioid
2
2023
991
0.520
Why?
Hospital Records
1
2016
12
0.520
Why?
Proteoglycans
1
2017
107
0.510
Why?
Atrial Fibrillation
3
2019
390
0.510
Why?
Hospital Mortality
6
2024
900
0.510
Why?
Ventricular Function, Left
5
2025
540
0.510
Why?
Artificial Intelligence
1
2019
272
0.500
Why?
Disease Management
1
2020
623
0.480
Why?
Survival
1
2015
38
0.480
Why?
Tetrazoles
1
2015
40
0.480
Why?
Middle Aged
29
2025
33200
0.480
Why?
Male
40
2025
67361
0.470
Why?
Biphenyl Compounds
1
2015
63
0.470
Why?
Muscle Proteins
2
2025
229
0.460
Why?
Myocardial Infarction
3
2018
1045
0.460
Why?
Research Design
1
2020
1107
0.440
Why?
Ventricular Remodeling
3
2025
262
0.430
Why?
Registries
2
2020
2015
0.430
Why?
Loperamide
2
2023
11
0.430
Why?
Myocardium
3
2017
1002
0.410
Why?
Adult
28
2024
37616
0.410
Why?
Tachycardia, Ventricular
1
2015
174
0.400
Why?
Diet
1
2021
1273
0.400
Why?
Precision Medicine
6
2024
426
0.400
Why?
Polymorphism, Single Nucleotide
4
2017
2190
0.400
Why?
Legislation, Medical
1
2012
11
0.390
Why?
Amiodarone
1
2012
26
0.390
Why?
Peripartum Period
4
2022
17
0.390
Why?
Quality Improvement
2
2020
1152
0.380
Why?
Patient Readmission
1
2018
695
0.380
Why?
Phenotype
5
2025
3199
0.380
Why?
Anti-Arrhythmia Agents
1
2012
114
0.370
Why?
Heart Arrest
4
2019
339
0.360
Why?
Catheter Ablation
1
2015
349
0.360
Why?
Sex Factors
4
2024
2068
0.350
Why?
Pyrazines
2
2008
91
0.350
Why?
Treatment Outcome
10
2025
10764
0.350
Why?
Transfusion Reaction
1
2011
46
0.340
Why?
Triazoles
2
2008
147
0.340
Why?
Cardiovascular Diseases
5
2024
2108
0.340
Why?
Forecasting
2
2024
384
0.340
Why?
Postoperative Complications
2
2020
2624
0.340
Why?
Heart-Assist Devices
1
2016
552
0.330
Why?
Echocardiography
3
2024
659
0.330
Why?
Patient Transfer
1
2012
165
0.330
Why?
Insurance, Health
1
2012
278
0.330
Why?
Patient Discharge
2
2021
896
0.320
Why?
Databases, Factual
5
2020
1347
0.310
Why?
Anemia
1
2011
170
0.310
Why?
Risk Factors
9
2024
10331
0.310
Why?
Thiazolidinediones
1
2010
137
0.310
Why?
Aged, 80 and over
7
2024
7569
0.310
Why?
Marketing
1
2008
32
0.300
Why?
Renal Insufficiency
1
2011
156
0.300
Why?
Genotype
3
2024
1919
0.300
Why?
Rhabdomyolysis
1
2008
22
0.300
Why?
Simvastatin
1
2008
61
0.290
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
45
0.290
Why?
Heart Ventricles
4
2017
792
0.290
Why?
Receptors, Adrenergic, beta-1
4
2019
46
0.280
Why?
Heart Rate
3
2025
823
0.280
Why?
Length of Stay
4
2024
1208
0.280
Why?
Electrocardiography
4
2019
628
0.280
Why?
Cytochrome P-450 CYP2D6
3
2022
30
0.280
Why?
Drug Industry
1
2008
108
0.280
Why?
Kaplan-Meier Estimate
3
2016
891
0.280
Why?
Proportional Hazards Models
4
2021
1260
0.270
Why?
Practice Patterns, Physicians'
3
2020
1294
0.270
Why?
Pharmacovigilance
2
2024
23
0.260
Why?
Elective Surgical Procedures
2
2020
180
0.250
Why?
Follow-Up Studies
6
2024
5115
0.250
Why?
Incidence
5
2024
2788
0.250
Why?
Biological Specimen Banks
3
2024
102
0.250
Why?
Emergency Service, Hospital
2
2020
2050
0.250
Why?
Patient Reported Outcome Measures
2
2020
400
0.240
Why?
Gene Expression Regulation
1
2015
2603
0.240
Why?
Cause of Death
2
2019
429
0.230
Why?
Glucose
1
2010
1019
0.230
Why?
New York
1
2024
129
0.220
Why?
Diabetic Cardiomyopathies
1
2024
36
0.220
Why?
Pandemics
3
2022
1619
0.220
Why?
Young Adult
9
2022
13126
0.220
Why?
Pregnancy
6
2022
6731
0.220
Why?
Acute Kidney Injury
2
2008
811
0.210
Why?
Diphenoxylate
1
2023
5
0.210
Why?
Randomized Controlled Trials as Topic
3
2021
1455
0.210
Why?
Adolescent
10
2020
21463
0.210
Why?
Monitoring, Physiologic
1
2024
267
0.200
Why?
Nonprescription Drugs
1
2023
66
0.200
Why?
Heart Defects, Congenital
2
2020
831
0.200
Why?
Medicare
2
2020
747
0.190
Why?
Prognosis
5
2020
4018
0.190
Why?
Naltrexone
1
2023
97
0.190
Why?
Insulin Resistance
1
2010
1201
0.180
Why?
Time Factors
3
2020
6792
0.180
Why?
Speech
1
2021
73
0.180
Why?
Red Meat
1
2021
18
0.180
Why?
Data Interpretation, Statistical
2
2020
349
0.180
Why?
Smartphone
1
2021
91
0.180
Why?
Drug Dosage Calculations
1
2020
23
0.170
Why?
Losartan
1
2020
14
0.170
Why?
Lisinopril
1
2020
13
0.170
Why?
Actigraphy
1
2021
109
0.170
Why?
Hypoglycemic Agents
1
2010
1281
0.170
Why?
Protective Factors
1
2021
93
0.170
Why?
Angioedema
1
2020
16
0.170
Why?
Hypertension
2
2020
1284
0.170
Why?
Cardiac Resynchronization Therapy
1
2021
46
0.170
Why?
Wearable Electronic Devices
1
2021
52
0.170
Why?
Turner Syndrome
1
2021
53
0.170
Why?
American Heart Association
2
2019
306
0.170
Why?
Referral and Consultation
2
2017
777
0.170
Why?
Data Accuracy
1
2020
63
0.170
Why?
Milk
1
2021
124
0.170
Why?
Biological Products
1
2023
215
0.160
Why?
California
2
2012
424
0.160
Why?
Indans
1
2020
11
0.160
Why?
Oxadiazoles
1
2020
33
0.160
Why?
Bionics
1
2019
12
0.160
Why?
Editorial Policies
1
2020
51
0.160
Why?
Medical Futility
1
2019
23
0.160
Why?
Medical Informatics
1
2020
100
0.160
Why?
Fingolimod Hydrochloride
1
2020
40
0.160
Why?
Software
2
2015
663
0.160
Why?
Medical Record Linkage
1
2020
64
0.160
Why?
Prescription Drugs
1
2020
109
0.160
Why?
Information Storage and Retrieval
1
2020
117
0.160
Why?
Drug Overdose
1
2023
344
0.150
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2020
76
0.150
Why?
Drug Prescriptions
1
2021
247
0.150
Why?
Sitagliptin Phosphate
2
2008
33
0.150
Why?
Medical Order Entry Systems
1
2019
43
0.150
Why?
Social Determinants of Health
1
2022
250
0.150
Why?
Child Health Services
1
2020
185
0.150
Why?
Dose-Response Relationship, Drug
4
2020
2045
0.150
Why?
Tobacco Use
1
2019
65
0.150
Why?
Cohort Studies
3
2021
5718
0.150
Why?
Computer Graphics
2
2015
41
0.150
Why?
Cluster Analysis
1
2019
495
0.140
Why?
Gene Regulatory Networks
2
2023
308
0.140
Why?
Receptors, Histamine H2
1
2017
8
0.140
Why?
Florida
1
2018
101
0.140
Why?
Advisory Committees
1
2019
219
0.140
Why?
Porins
1
1997
14
0.140
Why?
Neisseria gonorrhoeae
1
1997
25
0.140
Why?
Dyslipidemias
1
2019
176
0.130
Why?
Prospective Studies
4
2021
7583
0.130
Why?
Academic Medical Centers
1
2020
497
0.130
Why?
Nursing Assessment
1
2017
55
0.130
Why?
Antihypertensive Agents
1
2020
488
0.130
Why?
Pressure Ulcer
1
2017
35
0.130
Why?
Patient Participation
1
2020
416
0.130
Why?
Population Surveillance
1
2020
470
0.130
Why?
Heart Diseases
1
2020
359
0.130
Why?
Cardiology
1
2019
278
0.130
Why?
Hospitals, Teaching
1
2017
116
0.130
Why?
Tilidine
1
2016
2
0.130
Why?
Consensus
1
2019
679
0.120
Why?
Double-Blind Method
3
2025
1981
0.120
Why?
Genetic Markers
1
2017
344
0.120
Why?
Oxycodone
1
2016
44
0.120
Why?
Rheumatic Heart Disease
1
2015
5
0.120
Why?
Databases, Genetic
1
2017
236
0.120
Why?
Rheumatic Fever
1
2015
9
0.120
Why?
Sex Distribution
1
2016
376
0.120
Why?
Cholesterol Ester Transfer Proteins
1
2015
20
0.120
Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
38
0.120
Why?
Hospitals, Low-Volume
1
2015
22
0.120
Why?
Angiotensin II
1
2015
99
0.120
Why?
Naloxone
1
2016
120
0.120
Why?
Computational Biology
2
2017
645
0.120
Why?
Gene Expression Profiling
3
2017
1768
0.110
Why?
Hospitals, High-Volume
1
2015
44
0.110
Why?
Marijuana Use
1
2018
203
0.110
Why?
Immunosuppressive Agents
1
2020
890
0.110
Why?
Oligonucleotide Array Sequence Analysis
1
2017
765
0.110
Why?
Percutaneous Coronary Intervention
1
2020
478
0.110
Why?
Mothers
1
2020
752
0.110
Why?
United Kingdom
1
2015
315
0.110
Why?
International Classification of Diseases
1
2015
131
0.110
Why?
Biomarkers
2
2024
4158
0.110
Why?
Comorbidity
1
2019
1611
0.110
Why?
Age Factors
2
2019
3290
0.110
Why?
Chronic Disease
2
2020
1784
0.110
Why?
Narcotic Antagonists
1
2015
178
0.100
Why?
Gene Expression
2
2017
1499
0.100
Why?
Ventricular Dysfunction, Left
2
2020
389
0.100
Why?
Down-Regulation
1
2015
657
0.100
Why?
Cholesterol
1
2015
410
0.100
Why?
MicroRNAs
2
2017
697
0.100
Why?
Federal Government
1
2012
27
0.100
Why?
Coronary Artery Disease
1
2019
702
0.100
Why?
Myocytes, Cardiac
1
2017
528
0.100
Why?
RNA, Messenger
2
2017
2831
0.100
Why?
Drug Resistance
1
2012
169
0.100
Why?
Area Under Curve
1
2012
313
0.090
Why?
Patient Safety
1
2015
304
0.090
Why?
Genetic Predisposition to Disease
2
2017
2417
0.090
Why?
Opiate Substitution Treatment
1
2013
147
0.090
Why?
Colorado
4
2024
4491
0.090
Why?
Predictive Value of Tests
1
2017
2030
0.090
Why?
Gastrointestinal Hemorrhage
1
2012
132
0.090
Why?
Anti-Retroviral Agents
1
2013
232
0.090
Why?
Pregnancy Outcome
1
2013
409
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
1042
0.090
Why?
Bayes Theorem
1
2012
400
0.090
Why?
Survival Rate
1
2015
1969
0.090
Why?
Managed Care Programs
2
2022
129
0.080
Why?
Endoscopy, Gastrointestinal
1
2012
227
0.080
Why?
Genome-Wide Association Study
1
2017
1434
0.080
Why?
Delivery of Health Care
1
2017
939
0.080
Why?
Emergency Medical Services
1
2015
548
0.080
Why?
Multivariate Analysis
1
2012
1513
0.080
Why?
Severity of Illness Index
1
2017
2831
0.080
Why?
Pharmacogenomic Variants
2
2019
35
0.070
Why?
Primary Health Care
1
2019
1714
0.070
Why?
Drug Approval
1
2008
87
0.070
Why?
Vasodilator Agents
1
2010
331
0.070
Why?
Logistic Models
1
2012
2060
0.070
Why?
Kidney Function Tests
1
2007
159
0.070
Why?
Animals
3
2023
36768
0.070
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
251
0.060
Why?
Zimbabwe
2
2017
55
0.060
Why?
Opioid-Related Disorders
1
2013
504
0.060
Why?
Drug Therapy, Combination
1
2008
1059
0.060
Why?
Models, Biological
1
2012
1769
0.060
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
35
0.060
Why?
Case-Control Studies
1
2012
3537
0.060
Why?
Depression
2
2022
1402
0.060
Why?
Psychological Tests
1
2005
138
0.060
Why?
Osteoporosis, Postmenopausal
1
2004
41
0.060
Why?
Potassium Channels
1
2025
150
0.050
Why?
Cross-Sectional Studies
3
2022
5417
0.050
Why?
Mandible
1
2004
78
0.050
Why?
Receptors, Adrenergic
1
2023
33
0.050
Why?
Drug Administration Schedule
2
2020
783
0.050
Why?
Cardiovascular Agents
1
2025
160
0.050
Why?
Algorithms
3
2020
1686
0.050
Why?
Carcinoembryonic Antigen
1
2002
39
0.050
Why?
Antigens, Differentiation
1
2002
83
0.050
Why?
Child
5
2020
21968
0.050
Why?
Electronic Prescribing
1
2021
3
0.040
Why?
Antigens, Bacterial
1
2002
129
0.040
Why?
Cell Adhesion Molecules
1
2002
181
0.040
Why?
Vitamin K Epoxide Reductases
1
2020
12
0.040
Why?
Health Services Misuse
1
2020
34
0.040
Why?
Insurance Claim Reporting
1
2020
24
0.040
Why?
Antidepressive Agents
1
2022
235
0.040
Why?
Lymphocyte Count
1
2020
150
0.040
Why?
Morbidity
1
2020
322
0.040
Why?
Antigens, Neoplasm
1
2002
320
0.040
Why?
Membrane Glycoproteins
1
2002
500
0.040
Why?
Grounded Theory
1
2019
34
0.040
Why?
Antineoplastic Agents
1
2010
2129
0.040
Why?
Metoprolol
1
2019
40
0.040
Why?
Antigens, CD
1
2002
522
0.040
Why?
Aftercare
1
2020
209
0.040
Why?
Bias
1
2020
218
0.040
Why?
HIV Infections
1
2013
2812
0.040
Why?
Genomics
1
2024
790
0.040
Why?
Mice, Transgenic
1
2023
2162
0.040
Why?
Coronary Angiography
1
2020
312
0.040
Why?
Delivery of Health Care, Integrated
1
2020
256
0.030
Why?
Amino Acid Sequence
2
2002
2145
0.030
Why?
Static Electricity
1
1997
120
0.030
Why?
Exercise Test
1
2020
625
0.030
Why?
Molecular Sequence Data
2
2002
2903
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2017
81
0.030
Why?
Inpatients
1
2021
499
0.030
Why?
Focus Groups
1
2019
508
0.030
Why?
Frail Elderly
1
2017
129
0.030
Why?
Socioeconomic Factors
1
2020
1281
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2017
343
0.030
Why?
Puerperal Disorders
1
2016
32
0.030
Why?
Metabolic Networks and Pathways
1
2017
182
0.030
Why?
Physician-Patient Relations
1
2020
544
0.030
Why?
World Health Organization
1
2016
122
0.030
Why?
Neoplasms
1
2010
2644
0.030
Why?
Drug Combinations
1
2016
344
0.030
Why?
Decision Trees
1
2015
94
0.030
Why?
Data Mining
1
2015
115
0.030
Why?
Cell Membrane
1
1997
736
0.030
Why?
Blood Pressure
1
2020
1772
0.030
Why?
Biopsy
1
2017
1126
0.030
Why?
Reproducibility of Results
1
2020
3272
0.020
Why?
Pediatrics
1
2020
1112
0.020
Why?
Models, Genetic
1
2015
605
0.020
Why?
Mass Screening
2
2013
1262
0.020
Why?
Infant
2
2015
9442
0.020
Why?
Liver
1
2020
1938
0.020
Why?
Anthracyclines
1
2010
48
0.020
Why?
Child, Preschool
2
2015
11069
0.020
Why?
Trastuzumab
1
2010
101
0.020
Why?
Angiotensin Receptor Antagonists
1
2010
92
0.020
Why?
Signal Transduction
1
2023
5065
0.020
Why?
Clinical Trials as Topic
1
2015
1043
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
201
0.020
Why?
Program Evaluation
1
2013
886
0.020
Why?
Apoptosis
1
2017
2548
0.020
Why?
Injections, Intravenous
1
2007
205
0.020
Why?
Natriuretic Peptide, Brain
1
2007
101
0.020
Why?
Ultrasonography
1
2010
751
0.020
Why?
Infusions, Intravenous
1
2007
408
0.020
Why?
Mice
1
2023
17731
0.020
Why?
Creatinine
1
2007
498
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2010
804
0.010
Why?
Hospitals, University
1
2005
180
0.010
Why?
Dentists
1
2004
20
0.010
Why?
Femur Neck
1
2004
63
0.010
Why?
Bone Diseases, Metabolic
1
2004
62
0.010
Why?
Antibodies, Monoclonal
1
2010
1428
0.010
Why?
Absorptiometry, Photon
1
2004
253
0.010
Why?
Nurses
1
2005
173
0.010
Why?
Heparan Sulfate Proteoglycans
1
2002
26
0.010
Why?
Analysis of Variance
1
2004
1318
0.010
Why?
Bone Density
1
2004
487
0.010
Why?
HeLa Cells
1
2002
636
0.010
Why?
Binding Sites
1
2002
1308
0.010
Why?
Clinical Competence
1
2005
1093
0.010
Why?
Physicians
1
2005
897
0.010
Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)